Abstract:Objective:To investigate the expression of CREPT and CyclinD3 in NSCLC, and the role of them in NSCLC occurrence and development process. Methods:The expression of CREPT and CyclinD3 in 271 pairs of NSCLC and corresponding normal tissues were detected by immunohistochemical method. The correlation between CREPT and CyclinD3 expression as well as the difference in clinico-pathological parameters were analyzed by statistical method.Results: Positive staining of CREPT and CyclinD3 were in cytoplasm and nucleus. The positive expression rates of the CREPT and CyclinD3 protein in NSCLC was signiifcantly higher than those in the corresponding normal tissue (all P<0.001). The expression of CREPT and CyclinD3 were no signiifcant differences in among groups of lung adenocarcinoma and squamous cell lung cancer (P=0.638; P=0.503), butthere were extremely significant difference in pathological grading groups of NSCLC, adenocarcinoma, squamous cell carcinoma (all P<0.001). There were signiifcant difference in the CREPT and CyclinD3 expression among various groups of clinical stages and lymph node metastasis or not (P=0.025,P=0.001;P=0.003,P=0.026). The protein expression level of CREPT was positively related with that of CyclinD3 in NSCLC, adenocarcinoma, squamous cell carcinoma(r=0.458,r=0.393,r=0.468; allP<0.001).Conclusion: Our data suggest that CREPT and CyclinD3 were differentially expressed proteins in NSCLC tissues and corresponding normal tissues and those over-expressed proteins being crucial for NSCLC occurrence and development

Expression and correlation of CREPT and CyclinD3 in non-small cell lung cancer